Cancer Research Protocols

   Title of Study                                                                       Principal Investigator

BOSTON TRIAL: A Phase 3 Randomized, Controlled, Open-label Study of Selinexor, Bortezomib, and Dexamethasone (SVd) Versus Bortezomib, and Dexamethasone (Vd) in Patients with Relapsed or Refractory Multiple Myeloma (RRMM)

Dilip Patel, MD

INSIGHT-MM: A global, prospective, non-interventional, observational study of presentation, treatment patterns, and outcomes in multiple myeloma patients

Dilip Patel, MD

informCLL: A Disease Registry for Patients with Chronic Lymphocytic Leukemia

Dilip Patel, MD

Connect MDS and AML: The Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) Disease Registry

Dilip Patel, MD

A Prospective, Longitudinal, Observational Study in Newly Diagnosed Multiple Myeloma (MM) Patients to Assess the Relationship between Patient Outcomes, Treatment Regimens and Molecular Profiles

Dilip Patel, MD

Floating CTA Show: 
No
Share